Yanling Wu

1.8k total citations
41 papers, 1.4k citations indexed

About

Yanling Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yanling Wu has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Yanling Wu's work include DNA and Nucleic Acid Chemistry (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Yanling Wu is often cited by papers focused on DNA and Nucleic Acid Chemistry (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Yanling Wu collaborates with scholars based in China, Japan and Sudan. Yanling Wu's co-authors include Yoshimasa Tanaka, Wen Zhang, Wen Zhang, Annoor Awadasseid, Sulin Zhang, Hitoshi Sugiyama, Gary V. Désir, Peili Wang, Heino Velázquez and Jianchao Xu and has published in prestigious journals such as Circulation, Kidney International and Journal of Medicinal Chemistry.

In The Last Decade

Yanling Wu

39 papers receiving 1.4k citations

Peers

Yanling Wu
Stéphane Gobeil Canada
Denis E. Reyna United States
Yi‐Hsiung Lin Taiwan
Jun Ishizaki Japan
Mohamed Amessou France
Manoj Kumar Kashyap United States
Hailing Yang United States
Li Lai United States
Daichao Xu China
Stéphane Gobeil Canada
Yanling Wu
Citations per year, relative to Yanling Wu Yanling Wu (= 1×) peers Stéphane Gobeil

Countries citing papers authored by Yanling Wu

Since Specialization
Citations

This map shows the geographic impact of Yanling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Wu more than expected).

Fields of papers citing papers by Yanling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Wu. The network helps show where Yanling Wu may publish in the future.

Co-authorship network of co-authors of Yanling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Wu. A scholar is included among the top collaborators of Yanling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Wu. Yanling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Xingguang, et al.. (2025). SETBP1 Contributes to the Progression of Neuroblastoma Through Regulating EPHA7 Expression. Iranian Journal of Science. 49(6). 1511–1521. 1 indexed citations
2.
Zhang, Hua, Jacek Plewka, Caiyun Wu, et al.. (2024). Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-l1 inhibitors. European Journal of Medicinal Chemistry. 276. 116683–116683. 7 indexed citations
3.
Awadasseid, Annoor, et al.. (2024). Small molecule and PROTAC molecule experiments in vitro and in vivo, focusing on mouse PD-L1 and human PD-L1 differences as targets. Biomedicine & Pharmacotherapy. 172. 116257–116257.
4.
Zhang, Hua, et al.. (2023). PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2230388–2230388. 4 indexed citations
5.
Li, Yupeng, Xiaoyi Zhu, Yao He, et al.. (2023). Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction. Seminars in Cancer Biology. 91. 50–69. 31 indexed citations
6.
Huang, Qiong, Xiao Wang, An Chen, et al.. (2022). Design, synthesis and anti-tumor activity of novel benzothiophenonaphthalimide derivatives targeting mitochondrial DNA (mtDNA) G-quadruplex. Biochemical Pharmacology. 201. 115062–115062. 11 indexed citations
7.
Awadasseid, Annoor, et al.. (2022). Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapy. Biomedicine & Pharmacotherapy. 157. 114057–114057. 12 indexed citations
8.
Gu, Jingjing, Junyi Xin, Hanting Liu, et al.. (2022). Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population. Archives of Toxicology. 96(6). 1729–1737. 3 indexed citations
9.
Wang, Ming, Xudong Ma, Kang Zhou, et al.. (2021). Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways. Journal of Medicinal Chemistry. 64(9). 6021–6036. 11 indexed citations
10.
Awadasseid, Annoor, Qiang Yin, Yanling Wu, & Wen Zhang. (2021). Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection. Biomedicine & Pharmacotherapy. 142. 111957–111957. 13 indexed citations
11.
Narva, Suresh, et al.. (2020). Synthesis and Evaluation of Biphenyl-1,2,3-Triazol-Benzonitrile Derivatives as PD-1/PD-L1 Inhibitors. ACS Omega. 5(33). 21181–21190. 10 indexed citations
12.
Liu, Yuanlin, Ye Wang, Xiang Shen, et al.. (2020). Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis. Experimental and Molecular Pathology. 117. 104561–104561. 11 indexed citations
13.
Awadasseid, Annoor, Suresh Narva, Song Cao, et al.. (2020). Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure. Life Sciences. 258. 118252–118252. 20 indexed citations
14.
Chen, Yu, Yanling Wu, Haiqiang Yao, et al.. (2018). miRNA Expression Profile of Saliva in Subjects of Yang Deficiency Constitution and Yin Deficiency Constitution. Cellular Physiology and Biochemistry. 49(5). 2088–2098. 16 indexed citations
15.
Wu, Yanling, et al.. (2014). Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics. International Journal of Biological Sciences. 10(10). 1084–1096. 198 indexed citations
16.
Zhang, Sulin, Yanling Wu, & Wen Zhang. (2014). G‐Quadruplex Structures and Their Interaction Diversity with Ligands. ChemMedChem. 9(5). 899–911. 127 indexed citations
17.
Wu, Yanling, Ganesh N. Pandian, Yanping Ding, et al.. (2013). Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources. Chemistry & Biology. 20(11). 1311–1322. 19 indexed citations
18.
Liang, Jing, et al.. (2013). The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases. International Journal of Biological Sciences. 9(5). 435–443. 172 indexed citations
19.
20.
Wu, Yanling, Jie Zheng, Joel Linden, & Joseph Holoshitz. (2004). Genoprotective pathways. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 546(1-2). 93–102. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Gobeil Breakdown of academic impact, for papers by Denis E. Reyna Breakdown of academic impact, for papers by Yi‐Hsiung Lin Breakdown of academic impact, for papers by Jun Ishizaki Breakdown of academic impact, for papers by Mohamed Amessou Breakdown of academic impact, for papers by Manoj Kumar Kashyap Breakdown of academic impact, for papers by Hailing Yang Breakdown of academic impact, for papers by Li Lai Breakdown of academic impact, for papers by Daichao Xu
Rankless by CCL
2026